Copyright
©The Author(s) 2025.
World J Hepatol. Oct 27, 2025; 17(10): 110247
Published online Oct 27, 2025. doi: 10.4254/wjh.v17.i10.110247
Published online Oct 27, 2025. doi: 10.4254/wjh.v17.i10.110247
Figure 1 Study flow chart.
Qd: Once daily; FENa: Fractional excretion of sodium; RAAS: Renin-angiotensin-aldosterone system.
- Citation: Gao Y, Gao YY, Shi RY, Ji D, Wang Y, Xu L, Wang Q, Wu MH, You HL, Bu QS, Dong YX, Zhou LZ, Liu W, Song QK, Han Y, Wei H, Zhang XY, Hu ZJ. Effect of empagliflozin on fractional excretion of sodium in patients with cirrhosis and refractory ascites. World J Hepatol 2025; 17(10): 110247
- URL: https://www.wjgnet.com/1948-5182/full/v17/i10/110247.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i10.110247
